Jeffrey M. Leiden, Executive Chairman: Vertex Pharmaceuticals VRTX Sell · Filed 24/02/16

Trade details

Type: Insider sale
Amount: $1,951,189.8
Shares · price: 4,655 sh · $419.16 a share
Held after: 17,896 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Jeffrey M. LeidenExecutive Chairman
Trade date: 24/02/15
Filed: 24/02/16
Days to filing: 1 days

Sold 20.6% of holdings

Share of holding sold: 20.6%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/01/16~24/03/16

Jeffrey M. Leiden's recent trades

Jeffrey M. LeidenDirector
BuyOdyssey Therapeutics
Buy
Odyssey Therapeutics
ODTX
$100K
5,000 sh
$100K
Filed 05/11
Traded 05/08
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$7.1M
15,681 sh
$7.1M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$4.7M
10,360 sh
$4.7M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$3.5M
7,899 sh
$3.5M
Filed 25/12/05
Traded 25/12/03
Jeffrey M. LeidenExecutive Chairman
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$2.6M
5,880 sh
$2.6M
Filed 25/12/05
Traded 25/12/03